Chlorpropamide treatment restores the reduced carrageenan-induced paw edema and pleural exudate volume in diabetic rats

Inflammation Research

Volumn 57, Issue 9, 2008, Pages 438-443

  Sartoretto, J L ^a   Melo, G A ^b   Bersani Amado, C A ^b   Oliveira, M A ^a   Santos, R A ^a   Passaglia, R T ^a   Nigro, D ^a   Cuman, R K N ^b   Carvalho, M H ^a   Fortes, Zuleica Bruno ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Chlorpropamide; Diabetes; Paw edema; Pleurisy

Indexed keywords

CARRAGEENAN; CHLORPROPAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; EXUDATIVE PLEURISY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; LEUKOCYTE COUNT; LUNG VOLUME; MALE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PAW EDEMA; PLEURA FLUID; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD GLUCOSE; CARRAGEENAN; CHLORPROPAMIDE; DIABETES MELLITUS, EXPERIMENTAL; EDEMA; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; NITRIC OXIDE SYNTHASE TYPE II; PLEURISY; RATS; RATS, WISTAR; RNA, MESSENGER; STREPTOZOCIN;

EID: 58149121287     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-7211-x     Document Type: Article

References (26)

1. Garcia-Leme J, Bohm GM, Migliorini RH, de Souza MZ: Possible participation of insulin in the control of vascular permeability. Eur J Pharmacol 1974;29 (2):298-306.
2. Garcia Leme J, Morato M, Souza MZ: Anti-inflammatory action of glucagon in rats. Br J Pharmacol 1975;55 (1):65-8.
3. Cuman RK, Bersani-Amado CA, Fortes ZB: Influence of type 2 diabetes on the inflammatory response in rats. Inflamm Res 2001;50 (9):460-5.
4. Garcia-Leme J, Hamamura L, Migliorini RH, Leite MP: Influence of diabetes upon the inflammatory response of the rat. A pharmacological analysis. Eur J Pharmacol 1973;23 (1):74-81.
5. Fortes ZB, Garcia Leme J, Scivoletto R: Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine. Br J Pharmacol 1983;78 (1):39-48.
6. Fortes ZB, Garcia Leme J, Scivoletto R: Vascular reactivity in diabetes mellitus: possible role of insulin on the endothelial cell. Br J Pharmacol 1984;83 (3):635-43.
7. Fortes ZB, Scivoletto R, Garcia-Leme J: Functional changes in the microcirculation of alloxan-induced diabetic rats. Gen Pharmacol 1989;20 (5):615-20.
8. Sartoretto JL, Melo GA, Carvalho MH, Nigro D, Passaglia RT, Scavone C, Cuman RK, Fortes ZB: Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression. Life Sci 2005;77 (21):2676-89.
9. Sartoretto JL, Santos RA, Scavone C, Tostes RC, Nigro D, Carvalho MH, Cuman RK, Fortes ZB: The influence of improved glycaemic control with chlorpropamide on microvascular reactivity and nitric oxide synthase activity in diabetic rats. J Pharm Pharmacol. 2007;59(8):1117-23.
10. Portha B, Levacher C, Picon L, Rosselin G: Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 1974;23 (11):889-95.
11. Weir GC, Clore ET, Zmachinski CJ, Bonner-Weir S: Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes 1981;30 (7):590-5.
12. Bonner-Weir S. Regulation of pancreatic beta-cell mass in vivo: Recent Prog Horm Res 1994;49:91-104.
13. Movassat J, Saulnier C, Portha B: Insulin administration enhances growth of the beta-cell mass in streptozotocin-treated newborn rats. Diabetes 1997;46 (9):1445-52.
14. Leahy JL, Weir GC: Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration. Diabetes 1985;34 (7):653-9.
15. Iwase M, Kikuchi M, Nunoi K, Wakisaka M, Maki Y, Sadoshima S, Fujishima M: A new model of type 2 (non-insulin-dependent) diabetes mellitus in spontaneously hypertensive rats: diabetes induced by neonatal streptozotocin treatment. Diabetologia 1986;29 (11):808-11.
16. Grill V, Westberg M, Ostenson CG: B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia. J Clin Invest 1987;80 (3):664-9.
17. Welsh N, Hellerstrom C: In vitro restoration of insulin production in islets from adult rats treated neonatally with streptozotocin. Endocrinology 1990;126 (4):1842-8.
18. Hemmings SJ, Spafford D: Neonatal STZ model of type II diabetes mellitus in the Fischer 344 rat: characteristics and assessment of the status of the hepatic adrenergic receptors. Int J Biochem Cell Biol 2000;32 (8):905-19.
19. Sturgess NC, Ashford ML, Cook DL, Hales CN: The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985;2 (8453):474-5.
20. Rendell M: The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs 2004;64 (12):1339-58.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28 (7):412-9.
22. Pickavance LC, Brand CL, Wassermann K, Wilding JP: The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats. Br J Pharmacol 2005;144 (3):308-16.
23. Winter CA, Risley EA, Nuss GW: Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 1962;111:544-7.
24. Vinegar R, Truax JF, Selph JL: Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat. Proc Soc Exp Biol Med 1973;143 (3):711-4.
25. Rastelli VM, Akamine EH, Oliveira MA, Nigro D, Passaglia Rde C, Carvalho MH, Fortes ZB: Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. Inflamm Res 2005;54 (4):173-9.
26. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS: Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 2001;280 (3):F480-6.